ThinkSabio

$NNVC

$1.61▲ +5.2% YTD

3 SEC 13D/G filings tracked · Last updated Sep 23, 2026

Filing History
News
NNVC ▲ +5.2% - NanoViricides, Inc.
CP $1.61▲ +5.2%Sep 23, 2026 · ThinkSabio Blog

$NNVC - Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides…

News
NNVC ▼ -0.9% - NanoViricides, Inc.
CP $1.11▲ -0.9%Sep 8, 2026 · ThinkSabio Blog

$NNVC - Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Eb…

News
NNVC ▼ -0.8% - NanoViricides, Inc.
CP $1.23▲ -0.8%Aug 31, 2026 · ThinkSabio Blog

$NNVC - While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broa…